RAPT Therapeutics Ownership 2024 | Who Owns RAPT Therapeutics Now?
Institutional Ownership
8.93%
Insider Ownership
1.84%
Retail Ownership
89.23%
Institutional Holders
27.00
RAPT Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 13.55% | 0.00% | 5,235,521 | 15,866 | 0.30% | 15,968,340 | Jun 30, 2024 |
| VANGUARD GROUP INC | 8.05% | 0.00% | 3,108,268 | 615,418 | 24.69% | 9,480,217 | Jun 30, 2024 |
| COLUMN GROUP LLC | 6.94% | 11.47% | 2,680,621 | - | - | 8,175,894 | Jun 30, 2024 |
| BLACKROCK INC. | 6.32% | 0.00% | 2,439,830 | -32,323 | -1.31% | 7,441,481 | Jun 30, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4.47% | 0.56% | 1,725,000 | 225,000 | 15.00% | 5,261,250 | Jun 30, 2024 |
| MORGAN STANLEY | 3.05% | 0.00% | 1,178,895 | -726,439 | -38.13% | 3,595,630 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.65% | 0.00% | 1,024,061 | 781,906 | 322.89% | 3,123,386 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 2.41% | 0.00% | 932,541 | 643,031 | 222.11% | 2,844,250 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 2.35% | 0.00% | 907,413 | 637,272 | 235.90% | 2,767,610 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 2.06% | 0.01% | 796,080 | 520,368 | 188.74% | 2,428,044,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.83% | 0.01% | 707,300 | 706,900 | 176725.00% | 2,157,265 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.77% | 0.00% | 684,713 | 5,497 | 0.81% | 2,088,661 | Jun 30, 2024 |
| STATE STREET CORP | 1.74% | 0.00% | 671,785 | 12,383 | 1.88% | 2,048,944,000 | Jun 30, 2024 |
| EUCLIDEAN CAPITAL LLC | 1.70% | 0.25% | 657,899 | - | - | 2,006,592 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.59% | 0.00% | 612,305 | 186,702 | 43.87% | 1,867,530 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 1.41% | 0.19% | 545,000 | -32,100 | -5.56% | 1,662,250 | Jun 30, 2024 |
| ALPHABET INC. | 1.40% | 0.08% | 540,270 | - | - | 1,647,824 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 1.39% | 0.10% | 536,682 | -125,716 | -18.98% | 1,636,880 | Jun 30, 2024 |
| ARDSLEY ADVISORY PARTNERS LP | 1.29% | 0.22% | 500,000 | 97,500 | 24.22% | 1,525,000 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 1.29% | 0.09% | 496,750 | - | - | 1,515,088 | Jun 30, 2024 |
RAPT Therapeutics's largest institutional shareholder is FMR LLC, holding 13.55% of the company's total share outstanding, currently valued at $15.97M. The top 10 institutional shareholders own together 51.85% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COLUMN GROUP LLC | 6.94% | 11.47% | 2,680,621 | - | - | 8,175,894 | Jun 30, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4.47% | 0.56% | 1,725,000 | 225,000 | 15.00% | 5,261,250 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.78% | 0.29% | 300,000 | - | - | 915,000 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.82% | 0.26% | 315,000 | - | - | 960,750 | Jun 30, 2024 |
| EUCLIDEAN CAPITAL LLC | 1.70% | 0.25% | 657,899 | - | - | 2,006,592 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.52% | 0.25% | 200,000 | 200,000 | 100.00% | 610,000 | Jun 30, 2024 |
| ARDSLEY ADVISORY PARTNERS LP | 1.29% | 0.22% | 500,000 | 97,500 | 24.22% | 1,525,000 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 1.41% | 0.19% | 545,000 | -32,100 | -5.56% | 1,662,250 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 0.76% | 0.14% | 292,000 | - | - | 890,600 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.01% | 0.11% | 2,000 | -85,200 | -97.71% | 610,000 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 1.39% | 0.10% | 536,682 | -125,716 | -18.98% | 1,636,880 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 1.29% | 0.09% | 496,750 | - | - | 1,515,088 | Jun 30, 2024 |
| ALPHABET INC. | 1.40% | 0.08% | 540,270 | - | - | 1,647,824 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.40% | 0.08% | 154,625 | - | - | 471,606 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.25% | 0.03% | 97,805 | 97,805 | 100.00% | 298,305 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.19% | 0.03% | 75,000 | 75,000 | 100.00% | 228,750 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.09% | 0.01% | 35,480 | 35,480 | 100.00% | 108,214 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.09% | 0.01% | 36,654 | 36,654 | 100.00% | 112,000 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.13% | 0.01% | 48,525 | 3,824 | 8.55% | 148,001 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.37% | 0.01% | 144,362 | -13,280 | -8.42% | 440,304 | Jun 30, 2024 |
The largest RAPT Therapeutics shareholder by % of total assets is COLUMN GROUP LLC. The company owns 2.68M shares of RAPT Therapeutics (RAPT), representing 11.47% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 2.65% | 0.00% | 1,024,061 | 781,906 | 322.89% | 3,123,386 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.83% | 0.01% | 707,300 | 706,900 | 176725.00% | 2,157,265 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 2.41% | 0.00% | 932,541 | 643,031 | 222.11% | 2,844,250 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 2.35% | 0.00% | 907,413 | 637,272 | 235.90% | 2,767,610 | Jun 30, 2024 |
| VANGUARD GROUP INC | 8.05% | 0.00% | 3,108,268 | 615,418 | 24.69% | 9,480,217 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 2.06% | 0.01% | 796,080 | 520,368 | 188.74% | 2,428,044,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.21% | 0.00% | 467,182 | 456,275 | 4183.32% | 1,424,000 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.76% | 0.01% | 295,241 | 263,372 | 826.42% | 900,485 | Jun 30, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4.47% | 0.56% | 1,725,000 | 225,000 | 15.00% | 5,261,250 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.52% | 0.25% | 200,000 | 200,000 | 100.00% | 610,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.97% | 0.00% | 373,788 | 187,565 | 100.72% | 1,140,054 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.59% | 0.00% | 612,305 | 186,702 | 43.87% | 1,867,530 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.39% | 0.00% | 150,000 | 120,000 | 400.00% | 457,500 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.28% | 0.00% | 107,994 | 107,994 | 100.00% | 329,382 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.53% | 0.00% | 203,900 | 105,900 | 108.06% | 621,895 | Jun 30, 2024 |
| NORGES BANK | 0.26% | - | 100,300 | 100,300 | 100.00% | 305,915 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.25% | 0.03% | 97,805 | 97,805 | 100.00% | 298,305 | Jun 30, 2024 |
| ARDSLEY ADVISORY PARTNERS LP | 1.29% | 0.22% | 500,000 | 97,500 | 24.22% | 1,525,000 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.23% | 0.00% | 88,373 | 88,373 | 100.00% | 269,538 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.19% | 0.03% | 75,000 | 75,000 | 100.00% | 228,750 | Jun 30, 2024 |
As of Jun 30 2024, RAPT Therapeutics's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 781.91K stocks of RAPT, valued at $3.12M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.54% | 0.00% | 208,499 | -1,819,667 | -89.72% | 637,000 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -1,223,472 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 3.05% | 0.00% | 1,178,895 | -726,439 | -38.13% | 3,595,630 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | - | - | - | -420,000 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -313,262 | -100.00% | - | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -275,097 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -246,200 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.86% | 0.00% | 331,876 | -224,928 | -40.40% | 1,011,850 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.43% | 0.00% | 165,981 | -155,632 | -48.39% | 506,242 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | - | - | - | -137,308 | -100.00% | - | Jun 30, 2024 |
| REDMILE GROUP, LLC | 1.39% | 0.10% | 536,682 | -125,716 | -18.98% | 1,636,880 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.01% | 0.11% | 2,000 | -85,200 | -97.71% | 610,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.03% | - | 10,534 | -82,083 | -88.63% | 31,000 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | - | - | - | -80,642 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -73,088 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -66,700 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -61,834 | -100.00% | - | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -60,000 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -57,955 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -51,500 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, RAPT Therapeutics's biggest institutional seller is PRICE T ROWE ASSOCIATES INC /MD/. The company sold -1.82M shares of RAPT, valued at $637.00K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALTIUM CAPITAL MANAGEMENT LP | 0.52% | 0.25% | 200,000 | 200,000 | 100.00% | 610,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.28% | 0.00% | 107,994 | 107,994 | 100.00% | 329,382 | Jun 30, 2024 |
| NORGES BANK | 0.26% | - | 100,300 | 100,300 | 100.00% | 305,915 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.25% | 0.03% | 97,805 | 97,805 | 100.00% | 298,305 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.23% | 0.00% | 88,373 | 88,373 | 100.00% | 269,538 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.19% | 0.03% | 75,000 | 75,000 | 100.00% | 228,750 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.14% | 0.00% | 55,825 | 55,825 | 100.00% | 170,266 | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 0.14% | 0.00% | 53,993 | 53,993 | 100.00% | 164,000 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.14% | 0.00% | 53,645 | 53,645 | 100.00% | 163,617 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.09% | 0.01% | 35,480 | 35,480 | 100.00% | 108,214 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.05% | 0.00% | 17,421 | 17,421 | 100.00% | 53,135 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 16,139 | 16,139 | 100.00% | 49,224 | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | 0.04% | 0.01% | 16,070 | 16,070 | 100.00% | 49,014 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 14,643 | 14,643 | 100.00% | 44,661 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.03% | 0.00% | 10,900 | 10,900 | 100.00% | 33,245 | Jun 30, 2024 |
| CERITY PARTNERS LLC | 0.03% | 0.00% | 10,546 | 10,546 | 100.00% | 32,166 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.02% | 0.00% | 7,500 | 7,500 | 100.00% | 22,875 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,372 | 1,372 | 100.00% | 4,184 | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 0.00% | - | 914 | 914 | 100.00% | 2,787 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.00% | - | 700 | 700 | 100.00% | 2,135 | Jun 30, 2024 |
| PICTON MAHONEY ASSET MANAGEMENT | 0.00% | - | 435 | 435 | 100.00% | 1,000 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 257 | 257 | 100.00% | 742 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | 0.00% | - | 127 | 127 | 100.00% | 399 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 78 | 78 | 100.00% | 238 | Jun 30, 2024 |
RAPT Therapeutics's largest new institutional shareholder by number of shares is ALTIUM CAPITAL MANAGEMENT LP, purchased 200.00K shares, valued at $610.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | - | - | - | -1,223,472 | -100.00% | - | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | - | - | - | -420,000 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -313,262 | -100.00% | - | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -275,097 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -246,200 | -100.00% | - | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | - | - | - | -137,308 | -100.00% | - | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | - | - | - | -80,642 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -73,088 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -66,700 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -61,834 | -100.00% | - | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -60,000 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -57,955 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -51,500 | -100.00% | - | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -46,500 | -100.00% | - | Jun 30, 2024 |
| SWISS NATIONAL BANK | - | - | - | -44,000 | -100.00% | - | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -40,940 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -40,871 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -32,600 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -30,300 | -100.00% | - | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | - | - | - | -25,877 | -100.00% | - | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -24,259 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -21,400 | -100.00% | - | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -20,208 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -17,907 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -16,749 | -100.00% | - | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -16,003 | -100.00% | - | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | - | - | - | -15,751 | -100.00% | - | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | - | - | - | -14,940 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -14,743 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -14,556 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -13,594 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -13,192 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -11,300 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -11,160 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -7,500 | -100.00% | - | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -4,500 | -100.00% | - | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | - | - | - | -4,479 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,581 | -100.00% | - | Jun 30, 2024 |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | - | - | - | -1,159 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -886 | -100.00% | - | Jun 30, 2024 |
| COMERICA BANK | - | - | - | -222 | -100.00% | - | Jun 30, 2024 |
| DAIWA SECURITIES GROUP INC. | - | - | - | -101 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -27 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -7 | -100.00% | - | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
RAPT Therapeutics's largest sold out institutional shareholder by shares sold is PERCEPTIVE ADVISORS LLC, sold -1.22M shares, valued at -, as of undefined.
RAPT Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Alger ETF Trust | 3.64% | 25,859 | - | - | Dec 31, 2023 |
| HARTFORD HLS SERIES FUND II INC | 0.67% | 164,002 | - | - | Dec 31, 2023 |
| HSBC FUNDS | 0.29% | 9,370 | 3,800 | 68.22% | Jan 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.28% | 1,377,775 | -636,914 | -31.61% | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.13% | 466,322 | - | - | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.12% | 42,045 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.12% | 112,075 | 68,434 | 156.81% | Jan 31, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.10% | 26,154 | 7,907 | 43.33% | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.08% | 2,373,336 | 675,676 | 39.80% | Feb 29, 2024 |
| ALGER PORTFOLIOS | 0.08% | 28,993 | 9,966 | 52.38% | Dec 31, 2023 |
| BlackRock Health Sciences Trust II | 0.07% | 177,974 | - | - | Mar 31, 2024 |
| ALGER FUNDS II | 0.05% | 10,497 | -88,781 | -89.43% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 21,985 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.03% | 8,628 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 218,507 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.02% | 64,030 | -438,861 | -87.27% | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.02% | 25,161 | - | - | Feb 29, 2024 |
| VANGUARD HORIZON FUNDS | 0.02% | 363,450 | 347,744 | 2214.08% | Mar 31, 2024 |
| Humankind Benefit Corp | 0.02% | 338 | 91 | 36.84% | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 802,700 | - | - | Feb 29, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 24,403 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 52,767 | -2,469 | -4.47% | Mar 31, 2024 |
| UBS FUNDS | 0.01% | 38,054 | -502 | -1.30% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,548 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 21,999 | 341 | 1.57% | Feb 29, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.01% | 17,073 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,630,120 | -510,564 | -23.85% | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 44,125 | -27,826 | -38.67% | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 26,126 | -821 | -3.05% | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 4,243 | -448 | -9.55% | Jan 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 14,000 | 14,000 | - | Mar 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.00% | 27,960 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 524 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 3,442 | -20,906 | -85.86% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 84,059 | 4,773 | 6.02% | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 24,459 | 188 | 0.77% | Feb 29, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 20,735 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 285,127 | -726 | -0.25% | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 8,720 | 4,733 | 118.71% | Aug 31, 2023 |
| AMG FUNDS | 0.00% | 37,025 | - | - | Mar 28, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 39,590 | - | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 49,788 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,913 | - | - | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 93,915 | - | - | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 7,796 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 23,728 | -1,664 | -6.55% | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 100,106 | - | - | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 48,465 | -38,132 | -44.03% | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 87,900 | 10,815 | 14.03% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 6,628 | 80 | 1.22% | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 2,277 | - | - | Mar 28, 2024 |
| BlackRock ETF Trust | 0.00% | 473 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 8,720 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 4,030 | - | - | Jan 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 21,346 | 6,143 | 40.41% | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 13,141 | -206 | -1.54% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 4,826 | -560 | -10.40% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 8,459 | 1,355 | 19.07% | Feb 29, 2024 |
| Global X Funds | 0.00% | 16,631 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 139,852 | -16,422 | -10.51% | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 10,084 | -1,978 | -16.40% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 76,436 | 384 | 0.50% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,475 | - | - | Mar 31, 2024 |
| Series Portfolios Trust | 0.00% | 1,805 | 4,038 | -180.83% | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 154,599 | 10,206 | 7.07% | Feb 29, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 1,560 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 24,409 | - | - | Mar 28, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 3,455 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 206,723 | -150,882 | -42.19% | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 468 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 90 | - | - | Apr 30, 2021 |
| NORTHERN FUNDS | 0.00% | 23,608 | -636 | -2.62% | Mar 28, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 3,783 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 10,000 | - | - | Mar 31, 2024 |
| Tidal Trust II | 0.00% | 3,144 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 493 | - | - | Mar 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 1,843 | - | - | Mar 31, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 9,246 | - | - | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,901 | -17,742 | -90.32% | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 6,308 | 6,308 | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 1,323,481 | -58,903 | -4.26% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 84,926 | -9,390 | -9.96% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 134,473 | 16,414 | 13.90% | Feb 29, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 629 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 269 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 11,083 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 5,900 | 2,600 | 78.79% | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 13,628 | - | - | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,162 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 11,335 | -46 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,000 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 134 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,409 | -321 | -6.79% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 6,897 | 888 | 14.78% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,402 | -310 | -8.35% | Jan 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 596 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 69,182 | - | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 8,784 | - | - | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 817,012 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 127 | - | - | Feb 29, 2024 |
RAPT Therapeutics's largest mutual fund holder by % of total assets is "Alger ETF Trust", owning 25.86K shares, compromising 3.64% of its total assets.
RAPT Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 27 | -80.71% |
| 31 Mar, 24 | 140 | 19.66% |
| 31 Dec, 23 | 117 | 15.84% |
| 30 Sep, 23 | 101 | 1.00% |
| 30 Jun, 23 | 100 | -9.09% |
| 31 Mar, 23 | 110 | 12.24% |
| 31 Dec, 22 | 98 | -2.00% |
| 30 Sep, 22 | 100 | 13.64% |
| 30 Jun, 22 | 88 | 3.53% |
| 31 Mar, 22 | 85 | -21.30% |
| 31 Dec, 21 | 108 | -9.24% |
| 30 Sep, 21 | 119 | -9.16% |
| 30 Jun, 21 | 131 | 47.19% |
| 31 Mar, 21 | 89 | -1.11% |
| 31 Dec, 20 | 90 | 30.43% |
| 30 Sep, 20 | 69 | 30.19% |
| 30 Jun, 20 | 53 | 43.24% |
| 31 Mar, 20 | 37 | 37.04% |
| 31 Dec, 19 | 27 | - |
As of 30 Jun 24, 27 institutions are holding RAPT Therapeutics's shares, representing a decrease of -80.71% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 3,448,478 | -89.18% |
| 31 Mar, 24 | 31,861,728 | -8.92% |
| 31 Dec, 23 | 34,982,126 | 0.63% |
| 30 Sep, 23 | 34,763,427 | 2.09% |
| 30 Jun, 23 | 34,050,266 | 2.26% |
| 31 Mar, 23 | 33,297,114 | 3.59% |
| 31 Dec, 22 | 32,142,828 | 7.26% |
| 30 Sep, 22 | 29,968,297 | 0.77% |
| 30 Jun, 22 | 29,739,451 | 6.12% |
| 31 Mar, 22 | 28,023,171 | 0.61% |
| 31 Dec, 21 | 27,851,934 | 5.49% |
| 30 Sep, 21 | 26,402,711 | -0.93% |
| 30 Jun, 21 | 26,650,779 | 26.30% |
| 31 Mar, 21 | 21,101,600 | 3.21% |
| 31 Dec, 20 | 20,445,879 | 21.49% |
| 30 Sep, 20 | 16,829,467 | 11.95% |
| 30 Jun, 20 | 15,033,464 | 28.68% |
| 31 Mar, 20 | 11,682,591 | 27.83% |
| 31 Dec, 19 | 9,139,447 | - |
RAPT Therapeutics (RAPT) has 3.45M shares outstanding as of 30 Jun 24, down -89.18% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 8.93% | 0.13% |
| 31 Mar, 24 | 83.01% | 1.00% |
| 31 Dec, 23 | 91.20% | 1.11% |
| 30 Sep, 23 | 90.70% | 1.15% |
| 30 Jun, 23 | 88.95% | 1.18% |
| 31 Mar, 23 | 86.98% | 1.07% |
| 31 Dec, 22 | 90.06% | 1.14% |
| 30 Sep, 22 | 88.97% | 0.98% |
| 30 Jun, 22 | 95.50% | 1.06% |
| 31 Mar, 22 | 94.76% | 1.07% |
| 31 Dec, 21 | 94.29% | 1.18% |
| 30 Sep, 21 | 89.53% | 0.83% |
| 30 Jun, 21 | 104.15% | 1.44% |
| 31 Mar, 21 | 84.93% | 1.18% |
| 31 Dec, 20 | 84.72% | 1.79% |
| 30 Sep, 20 | 68.83% | 1.80% |
| 30 Jun, 20 | 61.77% | 2.45% |
| 31 Mar, 20 | 50.21% | 1.40% |
| 31 Dec, 19 | 59.91% | - |
As of 30 Jun 24, RAPT Therapeutics is held by 8.93% institutional shareholders, representing a 0.13% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 15 | -80.00% |
| 31 Mar, 24 | 75 | 19.05% |
| 31 Dec, 23 | 63 | 50.00% |
| 30 Sep, 23 | 42 | -12.50% |
| 30 Jun, 23 | 48 | -18.64% |
| 31 Mar, 23 | 59 | -6.35% |
| 31 Dec, 22 | 63 | 8.62% |
| 30 Sep, 22 | 58 | 31.82% |
| 30 Jun, 22 | 44 | 10.00% |
| 31 Mar, 22 | 40 | -9.09% |
| 31 Dec, 21 | 44 | -36.23% |
| 30 Sep, 21 | 69 | -14.81% |
| 30 Jun, 21 | 81 | 170.00% |
| 31 Mar, 21 | 30 | -49.15% |
| 31 Dec, 20 | 59 | 43.90% |
| 30 Sep, 20 | 41 | -6.82% |
| 30 Jun, 20 | 44 | 57.14% |
| 31 Mar, 20 | 28 | 3.70% |
| 31 Dec, 19 | 27 | - |
15 institutional shareholders have increased their position in RAPT stock as of 30 Jun 24 compared to 75 in the previous quarter (a -80.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | -73.33% |
| 31 Mar, 24 | 30 | -14.29% |
| 31 Dec, 23 | 35 | -7.89% |
| 30 Sep, 23 | 38 | 15.15% |
| 30 Jun, 23 | 33 | 10.00% |
| 31 Mar, 23 | 30 | 130.77% |
| 31 Dec, 22 | 13 | -38.10% |
| 30 Sep, 22 | 21 | -19.23% |
| 30 Jun, 22 | 26 | -7.14% |
| 31 Mar, 22 | 28 | -24.32% |
| 31 Dec, 21 | 37 | 23.33% |
| 30 Sep, 21 | 30 | 30.43% |
| 30 Jun, 21 | 23 | -14.81% |
| 31 Mar, 21 | 27 | 68.75% |
| 31 Dec, 20 | 16 | - |
| 30 Sep, 20 | 16 | 433.33% |
| 30 Jun, 20 | 3 | -40.00% |
| 31 Mar, 20 | 5 | - |
| 31 Dec, 19 | - | - |
8 institutional shareholders have reduced their position in RAPT stock as of 30 Jun 24 compared to 30 in the previous quarter (a -73.33% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 27 | -80.71% | 3,448,478 | -89.18% | 8.93% | 0.13% | 15 | -80.00% | 8 | -73.33% |
| 31 Mar, 24 | 140 | 19.66% | 31,861,728 | -8.92% | 83.01% | 1.00% | 75 | 19.05% | 30 | -14.29% |
| 31 Dec, 23 | 117 | 15.84% | 34,982,126 | 0.63% | 91.20% | 1.11% | 63 | 50.00% | 35 | -7.89% |
| 30 Sep, 23 | 101 | 1.00% | 34,763,427 | 2.09% | 90.70% | 1.15% | 42 | -12.50% | 38 | 15.15% |
| 30 Jun, 23 | 100 | -9.09% | 34,050,266 | 2.26% | 88.95% | 1.18% | 48 | -18.64% | 33 | 10.00% |
| 31 Mar, 23 | 110 | 12.24% | 33,297,114 | 3.59% | 86.98% | 1.07% | 59 | -6.35% | 30 | 130.77% |
| 31 Dec, 22 | 98 | -2.00% | 32,142,828 | 7.26% | 90.06% | 1.14% | 63 | 8.62% | 13 | -38.10% |
| 30 Sep, 22 | 100 | 13.64% | 29,968,297 | 0.77% | 88.97% | 0.98% | 58 | 31.82% | 21 | -19.23% |
| 30 Jun, 22 | 88 | 3.53% | 29,739,451 | 6.12% | 95.50% | 1.06% | 44 | 10.00% | 26 | -7.14% |
| 31 Mar, 22 | 85 | -21.30% | 28,023,171 | 0.61% | 94.76% | 1.07% | 40 | -9.09% | 28 | -24.32% |
| 31 Dec, 21 | 108 | -9.24% | 27,851,934 | 5.49% | 94.29% | 1.18% | 44 | -36.23% | 37 | 23.33% |
| 30 Sep, 21 | 119 | -9.16% | 26,402,711 | -0.93% | 89.53% | 0.83% | 69 | -14.81% | 30 | 30.43% |
| 30 Jun, 21 | 131 | 47.19% | 26,650,779 | 26.30% | 104.15% | 1.44% | 81 | 170.00% | 23 | -14.81% |
| 31 Mar, 21 | 89 | -1.11% | 21,101,600 | 3.21% | 84.93% | 1.18% | 30 | -49.15% | 27 | 68.75% |
| 31 Dec, 20 | 90 | 30.43% | 20,445,879 | 21.49% | 84.72% | 1.79% | 59 | 43.90% | 16 | - |
| 30 Sep, 20 | 69 | 30.19% | 16,829,467 | 11.95% | 68.83% | 1.80% | 41 | -6.82% | 16 | 433.33% |
| 30 Jun, 20 | 53 | 43.24% | 15,033,464 | 28.68% | 61.77% | 2.45% | 44 | 57.14% | 3 | -40.00% |
| 31 Mar, 20 | 37 | 37.04% | 11,682,591 | 27.83% | 50.21% | 1.40% | 28 | 3.70% | 5 | - |
| 31 Dec, 19 | 27 | - | 9,139,447 | - | 59.91% | - | 27 | - | - | - |
RAPT Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of RAPT Therapeutics's stock was made by Brockstedt Dirk G. on Jan 08 2024, selling 898 shares at $22.78 per share (valued at $20.46K).
RAPT Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 6 | - | - |
| Q1 2024 | 7 | 1 | 700.00% |
| Q4 2023 | 2 | 3 | 66.67% |
| Q3 2023 | 1 | 2 | 50.00% |
| Q2 2023 | 8 | 3 | 266.67% |
| Q1 2023 | 14 | 7 | 200.00% |
| Q4 2022 | 2 | 6 | 33.33% |
| Q3 2022 | 6 | 11 | 54.55% |
| Q2 2022 | 35 | 9 | 388.89% |
| Q1 2022 | 19 | 16 | 118.75% |
| Q4 2021 | 6 | 10 | 60.00% |
| Q3 2021 | 29 | 83 | 34.94% |
| Q2 2021 | 26 | 14 | 185.71% |
| Q1 2021 | 17 | 16 | 106.25% |
| Q4 2020 | 8 | 24 | 33.33% |
| Q3 2020 | 10 | 18 | 55.56% |
| Q2 2020 | 22 | 15 | 146.67% |
| Q1 2020 | 16 | - | - |
| Q4 2019 | 57 | 47 | 121.28% |
6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by RAPT Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 1 | - |
| Q4 2023 | - | 3 | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | 4 | 4 | 100.00% |
| Q4 2022 | - | 4 | - |
| Q3 2022 | - | 2 | - |
| Q2 2022 | 21 | 3 | 700.00% |
| Q1 2022 | - | 6 | - |
| Q4 2021 | 2 | 5 | 40.00% |
| Q3 2021 | 10 | 60 | 16.67% |
| Q2 2021 | 14 | 10 | 140.00% |
| Q1 2021 | - | 11 | - |
| Q4 2020 | 3 | 13 | 23.08% |
| Q3 2020 | 8 | 12 | 66.67% |
| Q2 2020 | 6 | 9 | 66.67% |
| Q1 2020 | - | - | - |
| Q4 2019 | 6 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of RAPT Therapeutics's stocks.
RAPT Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| ARVN | Arvinas, Inc. |
| IKNA | Ikena Oncology, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| TYRA | Tyra Biosciences, Inc. |
| CNTB | Connect Biopharma Holdings Limited |
| ANTX | AN2 Therapeutics, Inc. |
| HCWB | HCW Biologics Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| PHVS | Pharvaris N.V. |
| HOWL | Werewolf Therapeutics, Inc. |
| PEPG | PepGen Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| XLO | Xilio Therapeutics, Inc. |
| MOLN | Molecular Partners AG |
| ELYM | Eliem Therapeutics, Inc. |
RAPT Ownership FAQ
Who Owns RAPT Therapeutics?
RAPT Therapeutics is owned by institutional shareholders (8.93%), insiders (1.84%), and public (89.23%). The largest institutional shareholder of RAPT Therapeutics is FMR LLC (13.55% of total shares) and the top mutual fund owner is Alger ETF Trust (3.64% of total shares).
Who are the major institutional shareholders of RAPT Therapeutics?
RAPT Therapeutics's major institutional shareholders are FMR LLC, VANGUARD GROUP INC, COLUMN GROUP LLC, BLACKROCK INC., and KINGDON CAPITAL MANAGEMENT, L.L.C.. The top five shareholders own together 39.32% of the company's share outstanding.
How many RAPT Therapeutics shareholders are there?
As of Jun 2024, there are 27 institutional shareholders of RAPT Therapeutics.
What percentage of RAPT Therapeutics is owned by FMR LLC?
FMR LLC owns 5.24M shares of RAPT Therapeutics, representing 13.55% of the company's total shares outstanding, valued at $15.97M (as of Jun 2024).
What percentage of RAPT Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 3.11M shares of RAPT Therapeutics (RAPT), compromising 8.05% of the company, valued at $9.48M.
What percentage of RAPT Therapeutics is owned by COLUMN GROUP LLC?
COLUMN GROUP LLC is the third largest holder of RAPT Therapeutics. The company owns 2.68M of the company's shares outstanding (worth $8.18M).